News
The urology imaging systems market is projected to grow at a CAGR of 4% in the next five years. This growth is driven by the ...
The Healthcare Analytics Market is expected to expand at a CAGR of ~20% during the forecast period. Key factors driving this ...
The Global Generic Drugs Market achieved a valuation of $487.21 Billion in 2024 and is anticipated to exceed $898 Billion by ...
The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to ...
AUSTIN, TX / ACCESS Newswire / April 17, 2025 / Software Effective Solutions Corp. (OTC:SFWJ), doing business as Medcana, today announced it is proceeding with the acquisition of pharmaceutical ...
Guests will experience live demos, complimentary treatments, and giveaways totaling over $16,000 SOUTHLAKE, TX / ACCESS Newswire / April 17, 2025 / North Texas Plastic Surgery will host a grand ...
PARIS, FRANCE / ACCESS Newswire / April 17, 2025 / Tribun Health, a pioneer in AI-powered digital pathology, is proud to ...
Founded by former Microsoft and Amazon professionals, MalfyTech is a tech company that builds tailored Artificial ...
ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is ...
DEA Stalls Pharmaceutical Development, Defying President Trump's AgendaIt's clear that the DEA's prolonged delays in ...
PALO ALTO, CALIFORNIA / ACCESS Newswire / April 17, 2025 / Bioz, Inc. the frontrunner in AI-powered product credibility for ...
Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome (SBS) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results